Related Experiment Videos
Coronary artery bypass in patients with impaired left ventricular function
Annals of the Academy of Medicine, Singapore
|January 1, 1990
Summary
Myocardial revascularisation improves survival and symptoms in patients with severe left ventricular dysfunction. This coronary artery disease treatment offers acceptable risk and better outcomes than medical therapy.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Severe left ventricular dysfunction in coronary artery disease (CAD) patients poses treatment challenges.
- Myocardial revascularisation is a potential therapeutic option for improving outcomes in this high-risk group.
Purpose of the Study:
- To evaluate the efficacy and safety of myocardial revascularisation in patients with CAD and severe left ventricular dysfunction.
- To assess the impact on survival rates and symptom improvement.
Main Methods:
- Retrospective analysis of 22 consecutive patients with CAD and severe left ventricular dysfunction (LVEF 10-35%) undergoing aorta-coronary bypass.
- Follow-up data collected for survival and symptom assessment over a mean of 24 months.
Main Results:
- Hospital mortality was 9% (2/22), with 3 late deaths.
- 12 out of 17 assessed survivors reported symptom improvement; 3 became asymptomatic.
- Significant improvement in survival expectation and symptoms compared to medical management.
Conclusions:
- Myocardial revascularisation is a viable and safe option for selected CAD patients with severe left ventricular dysfunction.
- The procedure offers improved survival and symptomatic relief, surpassing medical therapy.
- Further research is warranted to confirm these preliminary findings in a larger cohort.